Form D · Biotechnology
AmideBio, LLC
Boulder, CO · CIK 0001483408
Offering snapshot reported Nov 6, 2017 · SEC filing
- Reported sold
- $764K Offering amount: $764K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 6, 2017 | Initial | $763,517 | No comparison | 9 | SEC filing |
| Apr 12, 2017 | Amendment | $396,000 | $48,000vs Dec 29, 2016 | 9 | SEC filing |
| Dec 29, 2016 | Amendment | $348,000 | $204,000vs Apr 13, 2016 | 8 | SEC filing |
| Apr 13, 2016 | Initial | $144,000 | No comparison | 3 | SEC filing |
| Jan 13, 2015 | Initial | $279,287 | No comparison | 5 | SEC filing |
| May 7, 2014 | Initial | $400,000 | No comparison | 4 | SEC filing |
| May 25, 2012 | Initial | $300,000 | No comparison | 6 | SEC filing |
| May 9, 2011 | Initial | $575,000 | No comparison | 5 | SEC filing |
| Feb 4, 2010 | Initial | $274,997 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298161
Source: Form D, filed Nov 6, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Abbott | Director |
| David Barker | Director |
| David Brunel | Director |
| Ruel C. Mercure | Director |
| Vincent P. Mihalik | Director |
| Mikhail Plam | Director, Executive |
| Michael H.B. Stowell | Director, Executive |
| Niles Utlaut | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2830 13 Th Street
Boulder, CO, 80304
Boulder, CO, 80304